Sacituzumab Govetican

sacituzumab govitecan · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sacituzumab Govetican, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer [Phase 2]

See pricing